Aurobindo Pharma Limited — Others, 03-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aurobindo Pharma has confirmed that details of securities dematerialized and rematerialized during the recent quarter have been duly submitted to all stock exchanges where its shares are listed. This ensures seamless tracking and transparency for shareholders regarding their holdings. The company continues to maintain compliance in its share transfer and depository operations, supporting smooth investor transactions and record-keeping.